Openness to and preference for attributes of biologic therapy prior to initiation among patients with rheumatoid arthritis: patient and rheumatologist perspectives and implications for decision making

References

• KvienTKEpidemiology and burden of illness of rheumatoid arthritisPharmacoeconomics200422111215157000
   PubMed Web of Science ®Google Scholar
• OngKLWuBJCheungBMBarterPJRyeK-AArthritis: its prevalence, risk factors, and association with cardiovascular diseases in the United States, 1999 to 2008Ann Epidemiol2013232808623218811
   PubMed Web of Science ®Google Scholar
• BartonJLPatient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapyPatient Prefer Adherence2009333534420016797
   PubMed Web of Science ®Google Scholar
• FiresteinGSEvolving concepts of rheumatoid arthritisNature2003423693735636112748655
   PubMed Web of Science ®Google Scholar
• DougadosMSoubrierMAntunezAPrevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: Results of an international, cross-sectional study (COMORA)Ann Rheum Dis2014731626824095940
   PubMed Web of Science ®Google Scholar
• Newhall-PerryKLawNRamosBDirect and indirect costs associated with the onset of seropositive rheumatoid arthritisJ Rheumatol20002751156116310813281
   PubMed Web of Science ®Google Scholar
• FurneriGMantovaniLBelisariASystematic literature review on economic implications and pharmacoeconomic issues of rheumatoid arthritisClin Exp Rheumatol2012304S7223072761
   PubMed Web of Science ®Google Scholar
• SinghJAFurstDEBharatA2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritisArthritis Care Res2012645625639
   PubMed Web of Science ®Google Scholar
• SinghJAChristensenRWellsGABiologics for rheumatoid arthritis: an overview of Cochrane reviewsCochrane Database Syst Rev200944CD00784819821440
   PubMed Web of Science ®Google Scholar
• DoanQVChiouC-FDuboisRWReview of eight pharmacoeconomic studies of the value of biologic DMARDs (adalimumab, etanercept, and infliximab) in the management of rheumatoid arthritisJ Manag Care Pharm200612755556916981801
   PubMed Web of Science ®Google Scholar
• IannoneFLopalcoGCantariniLGaleazziMLapadulaGEfficacy and safety of combination therapy for preventing bone damage in rheumatoid arthritisClin Rheumatol2016351192326581205
   PubMed Web of Science ®Google Scholar
• SmolenJSLandewéRBreedveldFCEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 updateAnn Rheum Dis201365820052014
   Google Scholar
• KeystoneECKavanaughAFSharpJTRadiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: A randomized, placebo-controlled, 52-week trialArthritis Rheum20045051400141115146409
   PubMed Web of Science ®Google Scholar
• SaagKGTengGGPatkarNMAmerican College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritisArthritis Rheum200859676278418512708
   PubMed Web of Science ®Google Scholar
• ScottDBiologics-based therapy for the treatment of rheumatoid arthritisClin Pharmacol Ther2012911304322166850
   PubMed Web of Science ®Google Scholar
• Van HulstLKievitWVan BommelRvan RielPFraenkelLRheumatoid arthritis patients and rheumatologists approach the decision to escalate care differently: results of a maximum difference scaling experimentArthritis Care Res2011631014071414
   PubMed Web of Science ®Google Scholar
• HuynhTKØstergaardAEgsmoseCMadsenORPreferences of patients and health professionals for route and frequency of administration of biologic agents in the treatment of rheumatoid arthritisPatient Prefer Adherence20148939924470758
   PubMed Web of Science ®Google Scholar
• CurkendallSPatelVGleesonMCampbellRZagariMDuboisRCompliance with biologic therapies for rheumatoid arthritis: Do patient out-of-pocket payments matter?Arthritis Rheum200859101519152618821651
   PubMed Web of Science ®Google Scholar
• BolgeSCGorenATandonNReasons for discontinuation of subcutaneous biologic therapy in the treatment of rheumatoid arthritis: A patient perspectivePatient Prefer Adherence2015912113125653505
   PubMed Web of Science ®Google Scholar
• LisickiRChuLWhat matters to patients and physicians when considering biologic therapy for rheumatoid arthritisPostgrad Med2008120315416018824833
   PubMed Web of Science ®Google Scholar
• WilliamsEEdwardsCPatient preferences in choosing anti-TNF therapies-R1Rheumatology (Oxford)200645121575157617085468
   PubMed Web of Science ®Google Scholar
• AugustovskiFBeratarrecheaAIrazolaVPatient preferences for biologic agents in rheumatoid arthritis: A discrete-choice experimentValue Health201316238539323538191
   PubMed Web of Science ®Google Scholar
• PoulosCHauberABGonzálezJMOgaleSTurpcuAPatient tradeoffs between frequency and duration of biologic treatments for rheumatoid arthritis. Poster presented at: The ISPOR 17th Annual International Meeting. Washington, DC, on June 2–6, 2012. [abstract]Value in Health2012154A42
   Web of Science ®Google Scholar
• ThompsonAPractical aspects of therapeutic intervention in rheumatoid arthritisJ Rheumatol Suppl200982394119509329
   PubMedGoogle Scholar
• KievitWVan HulstLVan RielPFraenkelLFactors that influence rheumatologists’ decisions to escalate care in rheumatoid arthritis: Results from a choice-based conjoint analysisArthritis Care Res2010626842847
   Web of Science ®Google Scholar
• WolfeFMichaudKResistance of rheumatoid arthritis patients to changing therapy: Discordance between disease activity and patients’ treatment choicesArthritis Rheum20075672135214217599730
   PubMed Web of Science ®Google Scholar
• BenhamouMRinchevalNRoyCThe gap between practice and guidelines in the choice of first-line disease modifying antirheumatic drug in early rheumatoid arthritis: results from the ESPOIR cohortJ Rheumatol200936593494219286850
   PubMed Web of Science ®Google Scholar
• LevinsonWKaoAKubyAThistedRANot all patients want to participate in decision making: A national study of public preferencesJ Gen Intern Med200520653153515987329
   PubMed Web of Science ®Google Scholar
• StevensonFABarryCABrittenNBarberNBradleyCPDoctor–patient communication about drugs: The evidence for shared decision makingSoc Sci Med200050682984010695980
   PubMed Web of Science ®Google Scholar
• WillekePBeckerHWassenbergSPavenstädtHJacobiAPatient/rheumatologist evaluation of infusion treatment for rheumatoid arthritisZ Rheumatol201170323223421359555
   PubMed Web of Science ®Google Scholar
• ScarpatoSAntivalleMFavalliEGPatient preferences in the choice of anti-TNF therapies in rheumatoid arthritis. Results from a questionnaire survey (RIVIERA study)Rheumatology (Oxford)201049228929419920093
   PubMed Web of Science ®Google Scholar
• MathewsALColeskaABurnsPBChungKCThe evolution of patient decision-making regarding medical treatment of rheumatoid arthritisArthritis Care Res (Hoboken)201668331832426315611
   PubMed Web of Science ®Google Scholar
• NeameRHammondADeightonCNeed for information and for involvement in decision making among patients with rheumatoid arthritis: a questionnaire surveyArthritis Rheum200553224925515818715
   PubMed Web of Science ®Google Scholar
• DillaTRenteroMLComellasMLizanLSacristánJAPatients’ preferences for rheumatoid arthritis treatments and their participation in the treatment decision-making process. A systematic review of the literatureValue Health2015187A65226533657
   PubMed Web of Science ®Google Scholar
• SandersonTCalnanMMorrisMRichardsPHewlettSThe impact of patient-perceived restricted access to anti-TNF therapy for rheumatoid arthritis: a qualitative studyMusculoskeletal Care20097319420919127529
   PubMedGoogle Scholar
• CharlesCGafniAWhelanTShared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango)Soc Sci Med19974456816929032835
   PubMed Web of Science ®Google Scholar
• MontgomeryAFaheyTHow do patients’ treatment preferences compare with those of clinicians?Qual Health Care200110suppl 1i39i4311533437
   PubMedGoogle Scholar
• ConstantinescuFGoucherSWeinsteinAFraenkelLRacial disparities in treatment preferences for rheumatoid arthritisMed Care200947335035519165120
   PubMed Web of Science ®Google Scholar